D. Clements
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
D. Clements has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
M. M. Davies
Llandough Hospital, Penarth, Cardiff, UK.E‐mail
2 shared publicationsD. Ramanathan
Department of Clincal Oncology, Velindre Hospital Cancer Centre, Cardiff, UK
1 shared publicationJ. Beynon
Consultant Colorectal Surgeon, Singleton Hospital, Swansea, UK.E‐mail
1 shared publicationN. D. Carr
Consultant Colorectal Surgeon
1 shared publicationP. Dhruva Rao
Department of Colorectal surgery, Llandough Hospital, Cardiff, UK
1 shared publication- Richard Adams
Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom
1 shared publication
Latest Publications
- 17 February 2010
- Published by Wiley in Colorectal Disease
- Vol. 12 (3) , 267-268
Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer
- 17 February 2010
- Published by Wiley in Colorectal Disease
- Vol. 12 (3) , 267-268
Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer
- 8 December 2009
- Published by Wiley in Colorectal Disease
- Vol. 12 (1) , 75
A letter in response to rectal cancer: involved CRM – a root cause analysis
- 8 December 2009
- Published by Wiley in Colorectal Disease
- Vol. 12 (1) , 75
A letter in response to rectal cancer: involved CRM – a root cause analysis
- 3 September 2009
- Published by Wiley in Colorectal Disease
- Vol. 11 (8) , 845-848
Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer
Objective The management of the asymptomatic primary in stage IV colorectal cancer presents a dilemma. There is an increased morbidity and mortality from surgical resection. Nonresectional management of the primary is associated with the risks of obstruction, perforation or haemorrhage. Our practice in patients with stage IV disease is palliative chemotherapy and symptom control. We reviewed our nonoperatively managed patients with colorectal liver metastases in order to identify the percentage of patients requiring urgent operative interventions for symptoms related to the primary.Subjects/patients and method A retrospective review of all patients treated for stage IV disease at our institution from 2003–2006 was undertaken. Patients were identified from multidisciplinary team (MDT) records. Demographic detail, treatment, and follow‐up data were extracted from hospital records. These were analysed with Microsoft Excel.Results Thirty‐seven patients were identified. 26 Male:11 Female. Median age 63 years (range 38–78). The median survival from diagnosis was 14 months. Three (8%) patients developed obstruction whilst having palliative chemotherapy. Two required a defunctioning stoma, and one was treated by means of a stent. There were no similarities between these three patients in terms of age, sex, site or stage of primary, volume of liver metastases, and alkaline phosphatase (ALP) or carcinoembryonic antigen (CEA) levels.Conclusion Of 37 patients initially treated palliatively for stage IV colorectal cancer, 92% required no surgical treatment of their primary. Therefore it is the experience of this MDT that it is acceptable to treat such patients in an expectant manner. It is not possible to predict those patients, likely to require surgical intervention.
- 3 September 2009
- Published by Wiley in Colorectal Disease
- Vol. 11 (8) , 845-848
Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer
Objective The management of the asymptomatic primary in stage IV colorectal cancer presents a dilemma. There is an increased morbidity and mortality from surgical resection. Nonresectional management of the primary is associated with the risks of obstruction, perforation or haemorrhage. Our practice in patients with stage IV disease is palliative chemotherapy and symptom control. We reviewed our nonoperatively managed patients with colorectal liver metastases in order to identify the percentage of patients requiring urgent operative interventions for symptoms related to the primary.Subjects/patients and method A retrospective review of all patients treated for stage IV disease at our institution from 2003–2006 was undertaken. Patients were identified from multidisciplinary team (MDT) records. Demographic detail, treatment, and follow‐up data were extracted from hospital records. These were analysed with Microsoft Excel.Results Thirty‐seven patients were identified. 26 Male:11 Female. Median age 63 years (range 38–78). The median survival from diagnosis was 14 months. Three (8%) patients developed obstruction whilst having palliative chemotherapy. Two required a defunctioning stoma, and one was treated by means of a stent. There were no similarities between these three patients in terms of age, sex, site or stage of primary, volume of liver metastases, and alkaline phosphatase (ALP) or carcinoembryonic antigen (CEA) levels.Conclusion Of 37 patients initially treated palliatively for stage IV colorectal cancer, 92% required no surgical treatment of their primary. Therefore it is the experience of this MDT that it is acceptable to treat such patients in an expectant manner. It is not possible to predict those patients, likely to require surgical intervention.